Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-009204

Chief Accounting Officer sold 36 shares at an average $9.51 ($342)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-23 Sale : show line 1 in the form −32 $9.45 $303 2,932 D
2025-01-23 Sale : show line 2 in the form −4 $9.94 $40 2,928 D
Open-market sales · 36 sh · avg $9.51 · $342
Loading xslF345X05/ownership.xml…